RecruitingNCT06805071
Decisional Regret in Open Partial Horizontal Laryngectomy
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
100 participants
Start Date
May 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Prospective multicentric study to evaluate decisional regret and psychometric and functional outcomes in patient previously treated with Open Horizontal partial Laryngectomy
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- SCC larynx treated with OPEN PARTIAL HORIZONTAL LARYNGECTOMY
Exclusion Criteria2
- Previous surgical treatment of the larynx
- Previous CT-RT of the head and neck district
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06805071
Related Trials
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
NCT069800383 locations
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
NCT02734537640 locations
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
NCT06532279143 locations
Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.
NCT053335239 locations
Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
NCT069149991 location